ConductScience.org, home

Paper42908720PubMed

PLXNB2 promotes breast cancer progression and lung metastasis through the AMPK signaling pathway.

Li X and 9 others. Am J Cancer Res, 2026.

Cite this record

ConductScience Library. PLXNB2 promotes breast cancer progression and lung metastasis through the AMPK signaling pathway. Papers, record 42908720. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42908720

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
PLXNB2 promotes breast cancer progression and lung metastasis through the AMPK signaling pathway.
Journal
Am J Cancer Res
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-10-24

Source PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li XXingqiao
2Cao FFei
3Liao MMingjuan
4Zhang YYing
5Suhaimi SAShafinah Ahmad
6Dahham SSSaad Sabbar
7Adam MAAMowaffaq Adam Ahmed
8Shahpudin SNMSiti Nurfatimah Mohd
9Sandai DDoblin
10Kang XXiaohong

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References23

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133514835Plexin-B2 facilitates glioblastoma infiltration by modulating cell biomechanics.Commun Biol2021https://conductscience.org/library/papers/33514835PubMed
239747004Invasion of glioma cells through confined space requires membrane tension regulation and mechano-electrical coupling via Plexin-B2.Nat Commun2025https://conductscience.org/library/papers/39747004PubMed
337632633Expression analysis, clinical significance and potential function of PLXNB2 in acute myeloid leukaemia.Mol Biol Rep2023https://conductscience.org/library/papers/37632633PubMed
434754128Treatment landscape of triple-negative breast cancer - expanded options, evolving needs.Nat Rev Clin Oncol2022https://conductscience.org/library/papers/34754128PubMed
536722641Mutated axon guidance gene PLXNB2 sustains growth and invasiveness of stem cells isolated from cancers of unknown primary.EMBO Mol Med2023https://conductscience.org/library/papers/36722641PubMed
633734139Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020.Chin Med J (Engl)2021https://conductscience.org/library/papers/33734139PubMed
721966369Plexin-B2 negatively regulates macrophage motility, Rac, and Cdc42 activation.PLoS One2011https://conductscience.org/library/papers/21966369PubMed
835195687AMP-activated protein kinase promotes breast cancer stemness and drug resistance.Dis Model Mech2022https://conductscience.org/library/papers/35195687PubMed
939828795Gene function revealed at the moment of stochastic gene silencingCommun Biol2025https://conductscience.org/library/papers/39828795PubMed
1023644529AMPK: a contextual oncogene or tumor suppressor?Cancer Res2013https://conductscience.org/library/papers/23644529PubMed
1138458752Biallelic variants in Plexin B2 (PLXNB2) cause amelogenesis imperfecta, hearing loss and intellectual disability.J Med Genet2024https://conductscience.org/library/papers/38458752PubMed
1233538338Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.CA Cancer J Clin2021https://conductscience.org/library/papers/33538338PubMed
1332193335Transcriptional suppression of AMPKα1 promotes breast cancer metastasis upon oncogene activation.Proc Natl Acad Sci U S A2020https://conductscience.org/library/papers/32193335PubMed
1425762646Plexin-B2 promotes invasive growth of malignant glioma.Oncotarget2015https://conductscience.org/library/papers/25762646PubMed
1539048831In vivo interaction screening reveals liver-derived constraints to metastasis.Nature2024https://conductscience.org/library/papers/39048831PubMed
1632321715AMPK Activation by Metformin Promotes Survival of Dormant ER+ Breast Cancer Cells.Clin Cancer Res2020https://conductscience.org/library/papers/32321715PubMed
1736423520HDLBP-stabilized lncFAL inhibits ferroptosis vulnerability by diminishing Trim69-dependent FSP1 degradation in hepatocellular carcinoma.Redox Biol2022https://conductscience.org/library/papers/36423520PubMed
1835665782Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.N Engl J Med2022https://conductscience.org/library/papers/35665782PubMed
1929100074Plexin-B2 Mediates Physiologic and Pathologic Functions of Angiogenin.Cell2017https://conductscience.org/library/papers/29100074PubMed
2031942000Chemosensitization of prostate cancer stem cells in mice by angiogenin and plexin-B2 inhibitors.Commun Biol2020https://conductscience.org/library/papers/31942000PubMed

See all 23 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42908720

GET https://conductscience.org/api/papers/v1/42908720/references?page=2